Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort ascending
Mar
19
2022
Gold Dome Report – Legislative Day 31 Nelson Mullins
Jun
20
2022
Transgender Youth and Access to Healthcare Nelson Mullins
Jan
31
2023
Old North State Report – Jan. 30, 2023 Nelson Mullins
Jan
18
2023
First Major Overhaul of Cosmetics Regulation Since FDR Administration Nelson Mullins
Jan
25
2023
FDA Finalizes Cannabis Guidance Focusing on Clinical Research and Quality Considerations Nelson Mullins
Jan
29
2024
Gold Dome Report – Legislative Day 10 (2024) Nelson Mullins
Apr
6
2023
FDA Announces First-Ever AI/ML Medical Device Draft Guidance Nelson Mullins
Jun
30
2023
Old North State Report – June 30, 2023 Nelson Mullins
Jul
12
2021
Biden Executive Order Addresses Healthcare Industry Competition, Targets Pharmaceuticals, Pricing, and Hospital Mergers Nelson Mullins
Apr
17
2023
FDA Publishes Implementation Policy Regarding Cybersecurity Requirements for Medical Device Premarket Submissions Nelson Mullins
Jun
12
2023
New FDA Draft Guidance Updates Recommendations for Good Clinical Practices Nelson Mullins
Jul
10
2023
Payment Cuts and Program Changes: CMS Issues Calendar Year 2024 Home Health Prospective Payment System Proposed Rule Nelson Mullins
Aug
31
2023
Two New Drug Supply Chain Security Act Guidance to Help Pharmaceutical Supply Chain Partners Comply with the DSCSA’s Move to Electronic Tracking Nelson Mullins
Oct
24
2023
FDA Updates Guidance Regarding Scientific Communications to HCPs about Unapproved Uses of Approved/Cleared Medical Devices and Drugs Nelson Mullins
Jan
22
2024
Gold Dome Report – Legislative Day 6 (2024) Nelson Mullins
Mar
1
2024
Gold Dome Report - Crossover Day Wrap-Up Nelson Mullins
Sep
14
2023
Stark Integrity Podcast: FCA, CARES Act, and Call Arrangements Episodes [Podcast] Nelson Mullins
Sep
21
2021
Changing Course, CMS Proposes to Repeal Medicare Coverage Pathway for FDA-Designated “Breakthrough Devices” Nelson Mullins
Oct
11
2021
HHS Rescinds Rule to Provide Insulin and Injectable Epinephrine at 340B Prices Nelson Mullins
Aug
15
2023
FDA Finalizes Informed Consent Guidance for Drug and Medical Device Clinical Investigations Nelson Mullins
Oct
3
2022
FDA Concludes Software Pre-Cert Pilot Program, Noting Federal Legislative Action is Needed Nelson Mullins
Feb
20
2023
Old North State Report – Feb. 20, 2023 Nelson Mullins
Jun
9
2023
Old North State Report – June 5, 2023 Nelson Mullins
Jul
18
2023
Hospital Price Transparency Changes in the Calendar Year 2024 Hospital Outpatient Prospective Payment System Proposed Rule Nelson Mullins
Sep
22
2021
Ushering in a New Era of OTC Drug Regulation, FDA Posts First Batch of “Deemed” Final Administrative Orders Nelson Mullins
Oct
26
2021
FDA Convenes Medical Device Workshop Focused on Artificial Intelligence and Machine Learning Transparency Nelson Mullins
Sep
24
2022
413 Pounds of Concealed Marijuana Intercepted by Cincinnati CBP U.S. Customs and Border Protection
Jan
7
2023
CBP Officers at the San Ysidro Port of Entry Seize Over $2 Million Worth of Cocaine U.S. Customs and Border Protection
Nov
7
2022
CBP Officers Seize $18.6 Million in Methamphetamine at Laredo Port of Entry U.S. Customs and Border Protection
Oct
24
2021
CBP Issues Withhold Release Order on Tomatoes Produced by Farm in Mexico U.S. Customs and Border Protection
Jun
26
2019
DOJ Enters into $225 Million Settlement with Opioid Manufacturer to Resolve Criminal and Civil Investigations Robinson & Cole LLP
Mar
16
2023
As COVID-19 Emergency Waivers End, DEA Proposes to Expand Tele-Prescribing of Controlled Substances Robinson & Cole LLP
Oct
7
2019
CMS Passes Final Rule Reducing Regulations Burdensome on Health Care Providers Robinson & Cole LLP
Oct
24
2019
Manufacturers are Not Immune to Claims that their Inventions are Patent-Ineligible Robinson & Cole LLP
Nov
7
2019
Medical Prescription Delivered by Drone Robinson & Cole LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins